학술논문
Phase i safety, pharmacokinetic, and pharmacodynamic study of SAR245409 (XL765), a novel, orally administered PI3K/mTOR inhibitor in patients with advanced solid tumors
Document Type
Article
Author
Source
In: Clinical Cancer Research . (Clinical Cancer Research, 1 May 2014, 20(9):2445-2456)
Subject
Language
English
ISSN
15573265
10780432
10780432